Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Beigene Ltd ADR (NQ: BGNE )

238.64 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 14, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 295
Open 238.64
Bid (Size) 220.00 (1)
Ask (Size) 300.00 (1)
Prev. Close 238.64
Today's Range 238.64 - 238.64
52wk Range 220.04 - 426.56
Shares Outstanding 1,211,067,023
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
BeiGene to Present at the J.P. Morgan 40th Annual Healthcare Conference
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global science-driven biotechnology company, today announced that the Company will participate in the J.P. Morgan 40th Annual Healthcare... 
From Business Wire News Releases
China NMPA Approves Tislelizumab as Second- or Third-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for... 
From Business Wire News Releases

Performance

YTD
-11.47%
-11.47%
1 Month
-12.84%
-12.84%
3 Month
-33.86%
-33.86%
6 Month
-25.56%
-25.56%
1 Year
-33.09%
-33.09%

More News

Read More
BeiGene Expands Collaboration with Novartis to Develop and Commercialize BeiGene’s TIGIT Inhibitor and Market Five Novartis Oncology Medicines in China Broad Markets
From Business Wire News Releases
BeiGene Announces Launch of Bioisland Innovation Center
From Business Wire News Releases
Death Cross Looms Over BeiGene Investors
Tags Market News Movers Markets
From Benzinga
Notable ETF Inflow Detected - AAXJ, XPEV, BGNE, TCOM
Tags ETFs
From ETF Channel
2 Risky Growth Stocks That Could Make You Filthy Rich
Tags SGEN AZN RHHBY
From Motley Fool
BeiGene Announces Closing of Its RMB22.2 Billion (US$3.5 Billion) Initial Public Offering on the STAR Market of the Shanghai Stock Exchange in China
From Business Wire News Releases
BAD ETF: The Top “Sin Stock” Holdings in the New Anti-ESG Fund That Debuts Today
Tags BAD RCAT AMGN
From InvestorPlace
Novartis Inks Option Agreement For BeiGene Anti-Cancer Therapy For Over $1B
Tags Briefs General News
From Benzinga
Nanjing Leads Biolabs and BeiGene Announce Worldwide License and Collaboration Agreement for LBL-007 Anti-LAG-3 Antibody; BeiGene Granted Exclusive Commercialization Rights Outside of China
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.